112 related articles for article (PubMed ID: 31078510)
1. Prevalence of abnormal cervical cancer screening outcomes among screening-compliant women in the United States.
Chido-Amajuoyi OG; Shete S
Am J Obstet Gynecol; 2019 Jul; 221(1):75-77. PubMed ID: 31078510
[No Abstract] [Full Text] [Related]
2. Prevalence of abnormal cervical cancer screening outcomes among women in the United States: results from the National Health Interview Survey, 2018.
Chido-Amajuoyi OG; Shete S; Talluri R; Shete S
Am J Obstet Gynecol; 2020 Dec; 223(6):938-941. PubMed ID: 32835712
[No Abstract] [Full Text] [Related]
3. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
4. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
5. The renewal of the National Cervical Screening Program.
Carter J
Med J Aust; 2016 Oct; 205(8):357-358. PubMed ID: 27736622
[No Abstract] [Full Text] [Related]
6. Evidence that supports policies to delay cervical screening until after age 25 years.
Dickinson JA; Ogilvie G; Van Niekerk D; Popadiuk C
CMAJ; 2017 Mar; 189(10):E380-E381. PubMed ID: 28385818
[No Abstract] [Full Text] [Related]
7. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
8. Cervical Cancer Screening.
Sawaya GF; Huchko MJ
Med Clin North Am; 2017 Jul; 101(4):743-753. PubMed ID: 28577624
[TBL] [Abstract][Full Text] [Related]
9. Whatever happened to the annual pap smear?
Vigliani MB
R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
[No Abstract] [Full Text] [Related]
10. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.
Roland KB; Soman A; Benard VB; Saraiya M
Am J Obstet Gynecol; 2011 Nov; 205(5):447.e1-8. PubMed ID: 21840492
[TBL] [Abstract][Full Text] [Related]
11. [New guidelines in regard to cervical cancer screening].
Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Jin XW; Xu H
Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus, current vaccines, and cervical cancer prevention.
Teitelman AM; Stringer M; Averbuch T; Witkoski A
J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
[TBL] [Abstract][Full Text] [Related]
15. Screening for breast and cervical cancer: understanding the different recommendations.
Somerall DW
Nurs Womens Health; 2013; 17(4):331-5. PubMed ID: 23957799
[TBL] [Abstract][Full Text] [Related]
16. Cervical Cancer Screening-Moving From the Value of Evidence to the Evidence of Value.
Sawaya GF
JAMA Intern Med; 2018 Oct; 178(10):1293-1295. PubMed ID: 30140917
[No Abstract] [Full Text] [Related]
17. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
18. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
19. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
20. Screening for Cervical Cancer.
Jin J
JAMA; 2018 Aug; 320(7):732. PubMed ID: 30140878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
